HLS Therapeutics Inc
OTC:HLTRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HLS Therapeutics Inc
OTC:HLTRF
|
CA |
|
W
|
Wha Utilities and Power PCL
SET:WHAUP
|
TH |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IST:PENTA.E
|
TR |
|
Titomic Ltd
ASX:TTT
|
AU |
|
G
|
General Commercial and Industrial SA
ATHEX:GEBKA
|
GR |
|
C
|
Cardno Ltd
OTC:COLDF
|
AU |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
K
|
Kumpulan Jetson Bhd
KLSE:JETSON
|
MY |
|
M
|
Man Industries India Ltd
NSE:MANINDS
|
IN |
|
N
|
NH Investment & Securities Co Ltd
KRX:005940
|
KR |
|
Union Pacific Corp
NYSE:UNP
|
US |
|
Althea Group Holdings Ltd
ASX:AGH
|
AU |
|
C
|
Crayon Group Holding ASA
OSE:CRAYN
|
NO |
Wall Street
Price Targets
HLTRF Price Targets Summary
HLS Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HLTRF
is 5.67 USD
with a low forecast of 3.08 USD and a high forecast of 8.63 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HLTRF's stock price target?
Price Target
5.67
USD
According to Wall Street analysts, the average 1-year price target for
HLTRF
is 5.67 USD
with a low forecast of 3.08 USD and a high forecast of 8.63 USD.
What is HLS Therapeutics Inc's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
HLS Therapeutics Inc's revenue is
-3%.
The projected
CAGR
for the next 3 years is
6%.
